Skip to main content

Gene Mutations dilated Cardiomyopathy

Comprehensive review on gene mutations contributing to dilated cardiomyopathy



Dilated cardiomyopathy (DCM) is one of the most common primary myocardial diseases. However, to this day, it remains an enigmatic cardiovascular disease (CVD) characterized by ventricular dilatation, which leads to myocardial contractile dysfunction. It is the most common cause of chronic congestive heart failure and the most frequent indication for heart transplantation in young individuals. Genetics and various other factors play significant roles in the progression of dilated cardiomyopathy, and variants in more than 50 genes have been associated with the disease. However, the etiology of a large number of cases remains elusive. Numerous studies have been conducted on the genetic causes of dilated cardiomyopathy.

These genetic studies suggest that mutations in genes for fibronectin, cytoskeletal proteins, and myosin in cardiomyocytes play a key role in the development of DCM. In this review, we provide a comprehensive description of the genetic basis, mechanisms, and research advances in genes that have been strongly associated with DCM based on evidence-based medicine. We also emphasize the important role of gene sequencing in therapy for potential early diagnosis and improved clinical management of DCM.

Clinical manifestation

Symptoms of DCM, such as dyspnea, fatigue, dizziness, syncope, and edema, may intermittently manifest in some patients during the early stages of DCM. However, these symptoms become more pronounced as the disease progresses to its severe stage (25). Uncommon yet significant signs and symptoms like abnormal skin pigmentation, skeletal myopathy, and neurosensory disorders (e.g., deafness, blindness) may indicate a specific form of multisystem disease or a unique DCM genotype. These symptoms are considered “red flags” for DCM diagnosis (26).

Conclusion

This review systematically summarizes the genes and mechanisms implicated in dilated cardiomyopathy, as well as the latest research directions in understanding its causes. It should be noted that with the advancement of medical technology, the diagnosis rate of dilated cardiomyopathy has been increasing. Nonetheless, patients often present with early onset, severe clinical manifestations, and poor prognosis. The standard approach for preventing or treating heart failure is currently the first-line treatment for patients with dilated cardiomyopathy. Cardiac resynchronization therapy and implantable cardioverter-defibrillators may be necessary to prevent life-threatening arrhythmias. It is recommended that all patients with dilated cardiomyopathy undergo sequencing of known cardiomyopathy genes. Gene-level therapy may represent a new approach for future treatments, although our current understanding of disease pathogenesis and gene therapy is primarily derived from preclinical animal models. This review also has some limitations, primarily that it only encompasses genes with substantial supporting evidence within the realm of evidence-based medicine. Due to the constraints of the review's length, there is a limited number of genes currently being researched and a lack of supporting experimental data. Consequently, some genes pertinent to “moderate classification” and “limited classification” have not been included in this review. Further research in this area is warranted.

Gene mutations in dilated cardiomyopathy (DCM) play a critical role in its pathogenesis, highlighting keywords like MYH7, TTN, LMNA, TNNT2, DSP, RBM20, SCN5A, ACTC1, PLN, TPM1, TNNI3, MYBPC3, BAG3, DES, CRYAB, LDB3, JPH2, GATA4, NKX2-5, ZASP, showcasing genetic and molecular insights into this cardiac condition

#DilatedCardiomyopathy, #GeneMutations, #CardiomyopathyResearch, #MYH7, #TTN, #LMNA, #TNNT2, #RBM20, #CardiacHealth, #HeartDisease, #DCMGenetics, #MedicalGenetics, #InheritedDisorders, #Cardiology, #GenomicResearch, #RareDiseases, #HeartFailure, #PrecisionMedicine, #CardiacGenes, #GeneticTesting

Comments

Post a Comment

Popular posts from this blog

Genetics role in ovarian cancer

The Medical Minute: Genetics play big role in ovarian cancer In 2024, about 19,680 women in the United States will receive a new diagnosis of ovarian cancer and 12,740 women will die from the disease, said Dr. Shaina Bruce , a gynecologic oncologist at Penn State Cancer Institute . The median age of all patients who develop ovarian cancer is 63. Historically, women at increased risk for ovarian cancer are recommended to have their fallopian tubes and ovaries removed when they have completed having children. Taking that step to protect themselves comes at a heavy price ― surgical menopause. But Bruce said medical science is catching up with ovarian cancer. Studies could lead to new methods for preventative care and the surgery needed to lower risk may be easier than it once was. Below, during Gynecologic Cancer Awareness Month, Bruce discusses the disease and why acting to reduce your risk is worth it. What’s the connection between heredity and ovarian cancer? About 25% of all cases of ...
Post a Comment
Read more

X chromosome

Gene on the X chromosome may help explain high multiple sclerosis rates in women Brain inflammation may be fueled by a gene on the X chromosome, a new study in mice suggests. And in female mice, who carry two X chromosomes, a diabetes drug called metformin may work to counteract that inflammation. If these findings bear out in later studies, they could help to unravel the long-standing mystery of why women, who have two copies of this inflammation-driving gene, are more prone to certain autoimmune diseases, particularly after menopause. A disparity between the sexes Our bodies are patrolled by immune cells that provide protection against bacteria and viruses, but sometimes, these defenses turn on us. In the autoimmune disorder multiple sclerosis (MS), for instance, the immune system attacks myelin, the fatty insulation surrounding the nerve fibers in the brain and spinal cord. This leads to symptoms such as muscle weakness and difficulty walking, as well issues with memory and thinking...
Post a Comment
Read more

Multifactorial Genetic Conditions

Multifactorial Genetic Conditions Multifactorial genetic conditions are disorders caused by the combined effects of multiple genes and environmental factors , rather than a single gene mutation . These conditions do not follow classic Mendelian inheritance patterns and instead result from complex gene–environment interactions . Factors such as lifestyle, nutrition, infections, stress, and exposure to toxins can significantly influence disease onset and severity in genetically susceptible individuals. Common examples include diabetes, cardiovascular diseases , neural tube defects, asthma, and many neuropsychiatric disorders. Understanding multifactorial inheritance is essential for risk prediction, preventive medicine, and personalized healthcare strategies. Multifactorial inheritance, polygenic traits, gene–environment interaction, complex diseases, genetic susceptibility, environmental risk factors, non-Mendelian inheritance, disease predisposition, polygenic risk score, precision ...
Post a Comment
Read more